Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism

Alessandro Serretti, Cristina Cusin, Francesco Benedetti, Laura Mandelli, Adele Pirovano, Raffaella Zanardi, Cristina Colombo, Enrico Smeraldi

Research output: Contribution to journalArticle

Abstract

Sleep disturbances are commonly observed in mood disorders, and sleep manipulations can influence the clinical status. In the present study, we investigated the possible effect of the 3111 T/C circadian locomotor output cycles kaput (CLOCK) gene polymorphism on insomnia symptomatology during antidepressant treatment. One hundred seventy-eight inpatients were treated with fluvoxamine 300 mg/day (n = 147) or paroxetine 20-40 mg/day (n = 31), and either placebo or pindolol in a double blind design for 6 weeks. The severity of depressive symptoms was weekly assessed with the Hamilton Rating Scale for Depression (HAM-D). We observed a significantly higher presence of insomnia throughout the trial in homozygotes for the C variant (P = 0.026). Other demographic and clinical features were found not to be related with CLOCK polymorphisms. Overall, our findings may suggest that CLOCK genotype influences the time course of insomnia during antidepressant treatment. This, together with previous findings on this polymorphism could lead to a further dissection of the complexity of mood disorders.

Original languageEnglish
Pages (from-to)36-39
Number of pages4
JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
Volume137 B
Issue number1
DOIs
Publication statusPublished - Aug 5 2005

Fingerprint

Sleep Initiation and Maintenance Disorders
Antidepressive Agents
Mood Disorders
Sleep
Depression
Genes
Fluvoxamine
Pindolol
Paroxetine
Homozygote
Dissection
Inpatients
Therapeutics
Genotype
Placebos
Demography

Keywords

  • Bipolar disorder
  • Circadian rhythm
  • CLOCK gene
  • Insomnia
  • Major depressive disorder
  • Pharmacogenetics

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. / Serretti, Alessandro; Cusin, Cristina; Benedetti, Francesco; Mandelli, Laura; Pirovano, Adele; Zanardi, Raffaella; Colombo, Cristina; Smeraldi, Enrico.

In: American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 137 B, No. 1, 05.08.2005, p. 36-39.

Research output: Contribution to journalArticle

Serretti, Alessandro ; Cusin, Cristina ; Benedetti, Francesco ; Mandelli, Laura ; Pirovano, Adele ; Zanardi, Raffaella ; Colombo, Cristina ; Smeraldi, Enrico. / Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. In: American Journal of Medical Genetics - Neuropsychiatric Genetics. 2005 ; Vol. 137 B, No. 1. pp. 36-39.
@article{d28543db9db649648b160acd1320543c,
title = "Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism",
abstract = "Sleep disturbances are commonly observed in mood disorders, and sleep manipulations can influence the clinical status. In the present study, we investigated the possible effect of the 3111 T/C circadian locomotor output cycles kaput (CLOCK) gene polymorphism on insomnia symptomatology during antidepressant treatment. One hundred seventy-eight inpatients were treated with fluvoxamine 300 mg/day (n = 147) or paroxetine 20-40 mg/day (n = 31), and either placebo or pindolol in a double blind design for 6 weeks. The severity of depressive symptoms was weekly assessed with the Hamilton Rating Scale for Depression (HAM-D). We observed a significantly higher presence of insomnia throughout the trial in homozygotes for the C variant (P = 0.026). Other demographic and clinical features were found not to be related with CLOCK polymorphisms. Overall, our findings may suggest that CLOCK genotype influences the time course of insomnia during antidepressant treatment. This, together with previous findings on this polymorphism could lead to a further dissection of the complexity of mood disorders.",
keywords = "Bipolar disorder, Circadian rhythm, CLOCK gene, Insomnia, Major depressive disorder, Pharmacogenetics",
author = "Alessandro Serretti and Cristina Cusin and Francesco Benedetti and Laura Mandelli and Adele Pirovano and Raffaella Zanardi and Cristina Colombo and Enrico Smeraldi",
year = "2005",
month = "8",
day = "5",
doi = "10.1002/ajmg.b.30130",
language = "English",
volume = "137 B",
pages = "36--39",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "wiley",
number = "1",

}

TY - JOUR

T1 - Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism

AU - Serretti, Alessandro

AU - Cusin, Cristina

AU - Benedetti, Francesco

AU - Mandelli, Laura

AU - Pirovano, Adele

AU - Zanardi, Raffaella

AU - Colombo, Cristina

AU - Smeraldi, Enrico

PY - 2005/8/5

Y1 - 2005/8/5

N2 - Sleep disturbances are commonly observed in mood disorders, and sleep manipulations can influence the clinical status. In the present study, we investigated the possible effect of the 3111 T/C circadian locomotor output cycles kaput (CLOCK) gene polymorphism on insomnia symptomatology during antidepressant treatment. One hundred seventy-eight inpatients were treated with fluvoxamine 300 mg/day (n = 147) or paroxetine 20-40 mg/day (n = 31), and either placebo or pindolol in a double blind design for 6 weeks. The severity of depressive symptoms was weekly assessed with the Hamilton Rating Scale for Depression (HAM-D). We observed a significantly higher presence of insomnia throughout the trial in homozygotes for the C variant (P = 0.026). Other demographic and clinical features were found not to be related with CLOCK polymorphisms. Overall, our findings may suggest that CLOCK genotype influences the time course of insomnia during antidepressant treatment. This, together with previous findings on this polymorphism could lead to a further dissection of the complexity of mood disorders.

AB - Sleep disturbances are commonly observed in mood disorders, and sleep manipulations can influence the clinical status. In the present study, we investigated the possible effect of the 3111 T/C circadian locomotor output cycles kaput (CLOCK) gene polymorphism on insomnia symptomatology during antidepressant treatment. One hundred seventy-eight inpatients were treated with fluvoxamine 300 mg/day (n = 147) or paroxetine 20-40 mg/day (n = 31), and either placebo or pindolol in a double blind design for 6 weeks. The severity of depressive symptoms was weekly assessed with the Hamilton Rating Scale for Depression (HAM-D). We observed a significantly higher presence of insomnia throughout the trial in homozygotes for the C variant (P = 0.026). Other demographic and clinical features were found not to be related with CLOCK polymorphisms. Overall, our findings may suggest that CLOCK genotype influences the time course of insomnia during antidepressant treatment. This, together with previous findings on this polymorphism could lead to a further dissection of the complexity of mood disorders.

KW - Bipolar disorder

KW - Circadian rhythm

KW - CLOCK gene

KW - Insomnia

KW - Major depressive disorder

KW - Pharmacogenetics

UR - http://www.scopus.com/inward/record.url?scp=23044441089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044441089&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.30130

DO - 10.1002/ajmg.b.30130

M3 - Article

C2 - 15952199

AN - SCOPUS:23044441089

VL - 137 B

SP - 36

EP - 39

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 1

ER -